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Hemoglobin is an important biochemical pigment seen
within erythrocytes. The hemoglobin is the most important
content within the red cell. It functions for oxygen carrying,
hence, it is very important for human beings. The abnormality of
hemoglobin is common in medical practice. The low hemoglo-
bin level from complete blood count is common problem in
medicine and it is called anemia. There are many causes of
anemia such as iron deﬁciency disorder and congenital hemo-
globin disorders. Thalassemia is a kind of hemoglobin disorder.
Thalassemia is due to the inherited abnormality of globin within
hemoglobin. The hemoglobin defect resulting in anemia is the
feature of thalassemia [1–10]. Thalassemia is an important
tropical anemia [1–10]. The patients affected with thalassemia
usually have abnormal iron metabolism and the
hemochromatosis is very common [1–3]. To manage thethalassemic patient is usually difﬁcult. To maintain the normal
hemoglobin level is the aim. However, the easily broken red
blood cell is usually the main challenge in clinical
management. To support the anemic symptoms of thalassemic
patients, transfusion becomes the widely used method.
However, the careful consideration is needed before having
transfusion therapy used. The transfusion management is
usually indicated in cases with severe anemia and this practice
can superimpose the severity of hemochromatosis [3]. Here,
the author tries to assess the physiological change of iron
metabolism in patients with thalassemia by using mathematical
model technique. The basic pathophysiological and biological
process on hemoglobin, iron, ferritin is used as basic
parameters for mathematical model development.
According to the mathematical modeling, there are some
differences between cases with and without transfusion
(Figures 1 and 2).article under the CC BY-NC-ND
Figure 2. Observational laboratory parameters in thalassemic patients with transfusion.
Figure 3. Change of iron in patients with transfusion.
FeOrg: Accumulated iron in organs.
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in Figure 3.
The data from these mathematical models can be useful for
further study on transfusion practice for thalassemic patients.
Indeed, mathematical model is a useful technique for clarifying
the complex pathophysiological process. In the present case, the
thalassemia, a complex genetic disease, has been studied. It can
be helpful for medical scientists to understand the molecular
pathology of disease [11]. There are extremely few reports on this
topic. A previously similar report was conducted by Ginzburg
and Rivella [12]. In that report, the complex biological process
was identiﬁed. However, there was still no exact mathematical
model study in that report [12].
In conclusion, the authors developed a mathematical model
study to help explain the pathophysiological change in thalas-
semic patients. Effect of standard transfusion therapy is
modeled. Also, the in vivo iron distribution is also mathemati-
cally studied. With this fundamental mathematical model, theeffect of transfusion regiment can be further simulated and
studied.
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